This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1994 Oct;13(10):933-4.

doi: 10.1097/00006454-199410000-00017.

Impaired immunity to pneumococcal polysaccharide antigens in children with human immunodeficiency virus infection immunized with pneumococcal vaccine

V B Peters¹, E P Diamant, D S Hodes, C O Cimino

Affiliations

PMID: 7854897
DOI: 10.1097/00006454-199410000-00017

Impaired immunity to pneumococcal polysaccharide antigens in children with human immunodeficiency virus infection immunized with pneumococcal vaccine

V B Peters et al. Pediatr Infect Dis J. 1994 Oct.

. 1994 Oct;13(10):933-4.

doi: 10.1097/00006454-199410000-00017.

Authors

V B Peters¹, E P Diamant, D S Hodes, C O Cimino

Affiliation

¹ Department of Pediatrics, Mount Sinai School of Medicine, New York, NY.

PMID: 7854897
DOI: 10.1097/00006454-199410000-00017

No abstract available

PubMed Disclaimer

Similar articles

Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine.
Arpadi SM, Back S, O'Brien J, Janoff EN. Arpadi SM, et al. J Pediatr. 1994 Jul;125(1):77-9. doi: 10.1016/s0022-3476(94)70127-x. J Pediatr. 1994. PMID: 8021792
Use of pneumococcal polysaccharide vaccine in children.
Obaro S, Leach A, McAdam KW. Obaro S, et al. Lancet. 1998 Aug 15;352(9127):575. doi: 10.1016/s0140-6736(05)79285-0. Lancet. 1998. PMID: 9716086 No abstract available.
Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial.
Ahmed F, Steinhoff MC, Rodriguez-Barradas MC, Hamilton RG, Musher DM, Nelson KE. Ahmed F, et al. J Infect Dis. 1996 Jan;173(1):83-90. doi: 10.1093/infdis/173.1.83. J Infect Dis. 1996. PMID: 8537687 Clinical Trial.
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.
Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, Mäkelä PH, Broome CV, Facklam RR, Tiesjema RH, et al. Robbins JB, et al. J Infect Dis. 1983 Dec;148(6):1136-59. doi: 10.1093/infdis/148.6.1136. J Infect Dis. 1983. PMID: 6361173 Review. No abstract available.
Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.
van Dam JE, Fleer A, Snippe H. van Dam JE, et al. Antonie Van Leeuwenhoek. 1990 Jun;58(1):1-47. doi: 10.1007/BF02388078. Antonie Van Leeuwenhoek. 1990. PMID: 2195989 Review. No abstract available.

See all similar articles

Cited by

Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres.
Seo JY, Seong SY, Ahn BY, Kwon IC, Chung H, Jeong SY. Seo JY, et al. Infect Immun. 2002 Mar;70(3):1143-9. doi: 10.1128/IAI.70.3.1143-1149.2002. Infect Immun. 2002. PMID: 11854194 Free PMC article.
Protective immunity of microsphere-based mucosal vaccines against lethal intranasal challenge with Streptococcus pneumoniae.
Seong SY, Cho NH, Kwon IC, Jeong SY. Seong SY, et al. Infect Immun. 1999 Jul;67(7):3587-92. doi: 10.1128/IAI.67.7.3587-3592.1999. Infect Immun. 1999. PMID: 10377143 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

1U01-AI27667/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information